SBIO: ALPS Medical Breakthroughs ETF - MutualFunds.com
Continue to site >
Trending ETFs

Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$46.56

-

0.00%

$0.00

0.50%

Vitals

YTD Return

-7.5%

1 yr return

13.4%

3 Yr Avg Return

7.7%

5 Yr Avg Return

15.3%

Net Assets

$213 M

Holdings in Top 10

27.0%

52 WEEK LOW AND HIGH

$47.03
$40.56
$63.63

Expenses

OPERATING FEES

Expense Ratio 0.50%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 88.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Exchange Traded Fund

Investment Style

Health


Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$46.56

-

0.00%

$0.00

0.50%

SBIO - Profile

Distributions

  • YTD Total Return -9.1%
  • 3 Yr Annualized Total Return 7.7%
  • 5 Yr Annualized Total Return 15.3%
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio -0.33%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    ALPS Medical Breakthroughs ETF
  • Fund Family Name
    ALPS
  • Inception Date
    Dec 30, 2014
  • Shares Outstanding
    4550000
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Ryan Mischker

Fund Description

The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.


SBIO - Performance

Return Ranking - Trailing

Period SBIO Return Category Return Low Category Return High Rank in Category (%)
YTD -7.5% -79.7% 42.7% 94.86%
1 Yr 13.4% -28.4% 92.6% 90.91%
3 Yr 7.7%* -0.3% 38.2% 93.24%
5 Yr 15.3%* 2.2% 38.6% 48.59%
10 Yr N/A* 9.4% 21.6% N/A

* Annualized

Return Ranking - Calendar

Period SBIO Return Category Return Low Category Return High Rank in Category (%)
2020 21.2% -13.6% 178.2% 27.17%
2019 50.2% 3.8% 63.8% 4.14%
2018 -14.2% -49.7% 21.5% 83.21%
2017 43.1% -59.8% 54.4% 5.93%
2016 -27.8% -36.6% 11.6% 96.88%

Total Return Ranking - Trailing

Period SBIO Return Category Return Low Category Return High Rank in Category (%)
YTD -9.1% -79.9% 39.5% 96.26%
1 Yr 13.4% -30.4% 92.6% 87.33%
3 Yr 7.7%* -15.9% 38.2% 90.50%
5 Yr 15.3%* -7.4% 38.6% 36.99%
10 Yr N/A* 9.4% 21.6% N/A

* Annualized

Total Return Ranking - Calendar

Period SBIO Return Category Return Low Category Return High Rank in Category (%)
2020 21.2% -13.6% 178.2% 27.17%
2019 50.2% 3.8% 63.8% 4.14%
2018 -14.2% -25.3% 22.2% 84.67%
2017 43.1% -10.8% 54.4% 6.67%
2016 -27.8% -36.6% 11.6% 99.22%

SBIO - Holdings

Concentration Analysis

SBIO Category Low Category High SBIO % Rank
Net Assets 213 M 2.72 M 53.2 B 67.05%
Number of Holdings 129 11 478 19.07%
Net Assets in Top 10 57.5 M 2.18 K 21.1 B 54.24%
Weighting of Top 10 26.95% 10.1% 94.7% 90.68%

Top 10 Holdings

  1. Mirati Therapeutics Inc 6.49%
  2. Acceleron Pharma Inc 4.33%
  3. Fate Therapeutics Inc 4.24%
  4. Vir Biotechnology Inc 3.95%
  5. Arrowhead Pharmaceuticals Inc 3.92%
  6. Blueprint Medicines Corp 3.66%
  7. United Therapeutics Corp 3.61%
  8. Allakos Inc 3.21%
  9. Apellis Pharmaceuticals Inc 3.12%
  10. Legend Biotech Corp ADR 3.05%

Asset Allocation

Weighting Return Low Return High SBIO % Rank
Stocks
100.03% 83.68% 101.79% 2.97%
Preferred Stocks
0.00% 0.00% 5.96% 61.44%
Other
0.00% -24.25% 9.11% 66.53%
Convertible Bonds
0.00% 0.00% 0.06% 58.05%
Bonds
0.00% 0.00% 15.36% 60.59%
Cash
-0.03% -0.65% 10.70% 94.49%

Stock Sector Breakdown

Weighting Return Low Return High SBIO % Rank
Healthcare
100.00% 61.99% 100.00% 25.00%
Utilities
0.00% 0.00% 0.98% 58.05%
Technology
0.00% 0.00% 19.13% 62.29%
Real Estate
0.00% 0.00% 6.13% 59.32%
Industrials
0.00% 0.00% 7.02% 60.59%
Financial Services
0.00% 0.00% 1.92% 72.03%
Energy
0.00% 0.00% 0.71% 58.05%
Communication Services
0.00% 0.00% 7.81% 60.17%
Consumer Defense
0.00% 0.00% 28.21% 61.44%
Consumer Cyclical
0.00% 0.00% 17.63% 58.90%
Basic Materials
0.00% 0.00% 8.23% 69.07%

Stock Geographic Breakdown

Weighting Return Low Return High SBIO % Rank
US
91.01% 57.23% 100.70% 31.78%
Non US
9.02% 0.00% 42.77% 58.47%

SBIO - Expenses

Operational Fees

SBIO Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.50% 0.08% 2.91% 61.21%
Management Fee 0.50% 0.00% 1.25% 20.90%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

SBIO Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

SBIO Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

SBIO Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 88.00% 0.00% 256.00% 82.04%

SBIO - Distributions

Dividend Yield Analysis

SBIO Category Low Category High SBIO % Rank
Dividend Yield 0.00% 0.00% 2.44% 62.29%

Dividend Distribution Analysis

SBIO Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Monthly Annually

Net Income Ratio Analysis

SBIO Category Low Category High SBIO % Rank
Net Income Ratio -0.33% -2.54% 1.92% 69.94%

Capital Gain Distribution Analysis

SBIO Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually

Dividend Payout History

View More +

SBIO - Fund Manager Analysis

Managers

Ryan Mischker


Start Date

Tenure

Tenure Rank

Mar 31, 2015

6.42

6.4%

Ryan Mischker is manager of Index Management. Mr. Mischker has oversight of the day-to-day operations of the department. Prior to joining ALPS Advisors, Mr. Mischker served as Compliance Manager of ALPS Fund Services, where he was primarily responsible for managing all post-trade monitoring for IRS, SEC and Prospectus/Statement of Additional Information investment guidelines and restrictions. Mr. Mischker has over 13 years financial services experience and graduated from the University of Northern Colorado with a B.S. in Finance and B.A. in Economics.

Andrew Hicks


Start Date

Tenure

Tenure Rank

Mar 31, 2016

5.42

5.4%

Andrew Hicks, Vice President of Index Management, of ALPS Advisors, Inc.. Mr. Hicks joined ALPS Advisors as a portfolio manager in 2015. Prior to joining ALPS Advisors, Mr. Hicks was a senior equity trader and research analyst with Virtus Investment Partners in New York City, specializing in ETF trading and international research. From 2007 to 2011, Mr. Hicks was an equity trader and research analyst at SCM Advisors in San Francisco, an affiliate of Virtus Investment Partners. With over many years of experience, Mr. Hicks gained international equity trading experience while at Wentworth, Hauser & Violich, and he began his career in semiconductor equity research at Citi. Mr. Hicks earned an accounting degree from Miami University (Ohio) while interning each summer on the American Stock Exchange in New York City.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.03 23.98 6.66 1.38